Status: current, Defined. Date: 31-May 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3060891000168117 | Ondansetron (Sandoz) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3060901000168118 | Ondansetron (Sandoz) 4 mg/2 mL injection, 2 mL ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ondansetron (Sandoz) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Ondansetron (Sandoz) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | Is a | ondansetron 4 mg/2 mL injection, ampoule | true | Inferred relationship | Some | ||
| Ondansetron (Sandoz) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Ondansetron (Sandoz) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | Is a | Ondansetron (Sandoz) | true | Inferred relationship | Some | ||
| Ondansetron (Sandoz) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
| Ondansetron (Sandoz) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | has unit of use | ampoule | true | Inferred relationship | Some | 1206464415 | |
| Ondansetron (Sandoz) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | has Australian BoSS | ondansetron | true | Inferred relationship | Some | 1206464414 | |
| Ondansetron (Sandoz) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | has intended active ingredient | ondansetron | true | Inferred relationship | Some | 1206464414 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ondansetron (Sandoz) 4 mg/2 mL injection, 5 x 2 mL ampoules | has TPUU | True | Ondansetron (Sandoz) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | Inferred relationship | Some | 1 |
| Ondansetron (Sandoz) 4 mg/2 mL injection, 5 x 2 mL ampoules | has TPUU | True | Ondansetron (Sandoz) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | Inferred relationship | Some | 1 |
| Ondansetron (Sandoz) 4 mg/2 mL injection, 2 mL ampoule | has TPUU | True | Ondansetron (Sandoz) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | Inferred relationship | Some | 1 |
| Ondansetron (Sandoz) 4 mg/2 mL injection, 2 mL ampoule | has TPUU | True | Ondansetron (Sandoz) (ondansetron 4 mg / 2 mL) injection, 2 mL ampoule (trade product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR